Trials / Conditions / Spinal Muscular Atrophy Type II

Spinal Muscular Atrophy Type II

9 registered clinical trials studyying Spinal Muscular Atrophy Type II.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Lim NCT06300996	Marco Capogrosso	N/A
Completed	Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain NCT06632730	Novartis	—
Unknown	Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy NCT06137612	University Hospital, Basel, Switzerland	—
Active Not Recruiting	Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi NCT04042025	Novartis Gene Therapies	Phase 3
Completed	Body Weight Support Harness System in Spinal Muscular Atrophy NCT05715749	Nationwide Children's Hospital	N/A
Active Not Recruiting	Spinraza in Adult Spinal Muscular Atrophy NCT03709784	Washington University School of Medicine	—
Completed	Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy NCT05416034	MarsiBionics	N/A
Completed	Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients. NCT01302600	Hoffmann-La Roche	Phase 2
Terminated	Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III NCT00439569	Westat	Phase 1 / Phase 2